Your browser doesn't support javascript.
loading
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
van den Heerik, Anne Sophie V M; Horeweg, Nanda; Nout, Remi A; Lutgens, Ludy C H W; van der Steen-Banasik, Elzbieta M; Westerveld, G Henrike; van den Berg, Hetty A; Slot, Annerie; Koppe, Friederike L A; Kommoss, Stefan; Mens, Jan Willem M; Nowee, Marlies E; Bijmolt, Stefan; Cibula, David; Stam, Tanja C; Jurgenliemk-Schulz, Ina M; Snyers, An; Hamann, Moritz; Zwanenburg, Aleida G; Coen, Veronique L M A; Vandecasteele, Katrien; Gillham, Charles; Chargari, Cyrus; Verhoeven-Adema, Karen W; Putter, Hein; van den Hout, Wilbert B; Wortman, Bastiaan G; Nijman, Hans W; Bosse, Tjalling; Creutzberg, Carien L.
Afiliación
  • van den Heerik ASVM; Radiation Oncology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands a.v.m.van_den_heerik@lumc.nl.
  • Horeweg N; Radiation Oncology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Nout RA; Radiation Oncology, Erasmus Medical Center - Cancer Institute, Rotterdam, Zuid-Holland, The Netherlands.
  • Lutgens LCHW; Radiation Oncology, Maastricht University Medical Centre+, Maastricht, Limburg, The Netherlands.
  • van der Steen-Banasik EM; Radation Oncology, Radiotherapy Group, Arnhem, Gelderland, The Netherlands.
  • Westerveld GH; Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands.
  • van den Berg HA; Radiation Oncology, Catharina Hospital, Eindhoven, Noord-Brabant, The Netherlands.
  • Slot A; Radiation Oncology, Radiotherapy Institute Friesland, Leeuwarden, Friesland, The Netherlands.
  • Koppe FLA; Radiation Oncology, Institute Verbeeten, Tilburg, Noord-Brabant, The Netherlands.
  • Kommoss S; Women's Health, Universitätsklinikum Tübingen, Tübingen, Baden-Württemberg, Germany.
  • Mens JWM; Radiation Oncology, Erasmus Medical Center - Cancer Institute, Rotterdam, Zuid-Holland, The Netherlands.
  • Nowee ME; Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, The Netherlands.
  • Bijmolt S; Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Groningen, The Netherlands.
  • Cibula D; Gynecologic Oncology Centre, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Stam TC; Radiation Oncology, Haaglanden Medical Center, Den Haag, Zuid-Holland, The Netherlands.
  • Jurgenliemk-Schulz IM; Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Snyers A; Radiation Oncology, Radboudumc, Nijmegen, Gelderland, The Netherlands.
  • Hamann M; Women's Health, Rotkreuzklinikum Munchen, Munchen, Bayern, Germany.
  • Zwanenburg AG; Radiation Oncology, Isala Klinieken, Zwolle, Overijssel, The Netherlands.
  • Coen VLMA; Radiation Oncology, Zuidwest Radiotherapeutic Institute, Vlissingen, Zeeland, The Netherlands.
  • Vandecasteele K; Radiation Oncology, University Hospital Ghent, Gent, Oost-Vlaanderen, Belgium.
  • Gillham C; Radiation Oncology, St. Luke's Hospital Dublin, Dublin, Ireland.
  • Chargari C; Radiation Oncology, Institut Gustave-Roussy, Villejuif, Île-de-France, France.
  • Verhoeven-Adema KW; Comprehensive Cancer Centre Utrecht, Utrecht, The Netherlands.
  • Putter H; Medical Statistics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • van den Hout WB; Biomedical Data Sciences, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Wortman BG; Radiation Oncology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Nijman HW; Obstetrics & Gynecology, University Medical Centre Groningen, University of Groningen, Groningen, Groningen, The Netherlands.
  • Bosse T; Pathology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
  • Creutzberg CL; Radiation Oncology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Int J Gynecol Cancer ; 30(12): 2002-2007, 2020 12.
Article en En | MEDLINE | ID: mdl-33046573
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Carcinoma Endometrioide Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Carcinoma Endometrioide Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido